Pfizer Stock News

The European Medicines Agency''s safety committee has confirmed a “very rare” risk of myocarditis and pericarditis in individuals who''ve had the Pfizer-BioNTech or Moderna Covid vaccines, having conducted large Europe-wide studies. Read Full Article at RT.com

German biotech company BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant , said its CEO Ugur Shahin, adding that despite the mutations, the vaccines must continue to protect people against serious illness. BioNTech and Pfizer Inc. together created one of the first vaccines against Covid-19, with more than 2 billion doses already available to humans worldwide. However, there are concerns that vaccines may not work as well against the Omicron variant, which appeared last month. "This option may be able to infect vaccinated people. However, we expect that infected people who have been vaccinated can still be protected against serious illness," Shahin said in an interview with Friday''s Reuters Next conference. The chief executive of BioNTech, whose work until the advent of the Covid-19 coronavirus in 2020 focused on cancer, said the new variant came earlier than expected. "This highly mutant coronavirus came earlier than I expected.

Investors who upgraded their portfolios with cannabis-focused Real Estate Investment Trust - Innovative Industrial Properties (NYSE:

FDA Expedites Review Process For Omicron Vaccines And Drugs It''s been one week since the omicron variant first rattled markets and prompted the Federal Reserve''s latest rethink of its plans for rolling back its monetary stimulus. And in that time, vaccine-makers have talked their book by sharing plans to produce new omicron-targeted vaccines, while others claim that there are no data suggesting the Pfizer-BioNTech jab is less effective against omicron. Assuming the world still does care about omicron three months from now (the first cases of the variant have only just been confirmed in the US in recent days), the FDA and its advisors are reportedly working on an expedited approval process that will allow "tweaked" versions of extant vaccines and remedies to be sheperded through in a matter of weeks. WSJ reports that the FDA has been quietly meeting with drug makers to establish guidelines for expedited approval of the next generation of vaccines, if they''re needed (and that''s still a big "if").

Bristlecone Advisors LLC lessened its stake in Pfizer Inc. (NYSE:PFE) by 4.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,248 shares of the biopharmaceutical companys stock after selling 494 shares during the quarter. Bristlecone Advisors LLCs holdings in Pfizer were []

The German company BioNTech, which has developed a coronavirus vaccine together with its US partner Pfizer, is ready to adapt its vaccine to the omicron strain, director-general and co-founder of the pharmaceutical company Ugur Shahin said on December 3

The global Calcium Channel Blocker market was valued at 72.3 Million USD in 2020 and will grow with a CAGR of 1.53% from 2021 to 2027. The increased prevalence of cardiovascular disorders and the adoption of a sedentary lifestyle are

OLONGAPO CITY---Medical frontliners at the city''s major COVID-19 facility on Friday (Dec. 3) began receiving the booster shot against COVID-19, local officials said. At least 500 workers of James L. Gordon Memorial Hospital (JLGMH) who had been fully inoculated six months ago were the first to receive the booster shot, according to the hospital management. Pfizer''s third dose was given to the vaccine recipients during the rollout on Friday morning, it said. So far, at least 108,151 residents or 60 percent of the target population had already been fully vaccinated against the viral disease while 161,818 received their first dose. The city has to vaccinate 182,000 residents Keep on reading: 500 hospital staff in Olongapo start getting booster shot vs COVID-19

Despite some risks, there''s a pretty good case to be made for the big pharma stock.

The research reports on Large Volume Parenteral (LVP) Market report gives detailed overview of factors that affect global business scope. Large Volume Parenteral (LVP) Market report shows the latest market insights with upcoming trends and breakdowns of products and services.

The European Medicines Agency said today it had begun reviewing a new vaccine against COVID-19, produced by the French company Valneva - the first step towards approving its use in the European Union, the Associated Press reported. A possible approval from the drug regulator would add another vaccine to the EU''s arsenal in the fight against COVID-19 at a time when the 27-member community is expanding booster doses and some countries are preparing to give the Pfizer vaccine to older children between 5 and 11 years. Last month, the European Commission approved a contract with Valneva to buy nearly 27 million doses in 2022. The agreement also includes the possibility of adapting the vaccine to new variants of the virus and buying another 33 million doses in 2023.

Equities analysts expect that Pfizer Inc. (NYSE:PFE) will report $23.79 billion in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Pfizers earnings, with estimates ranging from $23.57 billion to $24.20 billion. Pfizer reported sales of $11.68 billion in the same quarter last year, which would suggest a positive year []

Annual vaccines to tackle Covid-19 are likely to be needed, the boss of pharmaceutical giant Pfizer has said. Dr Albert Bourla said yearly vaccinations could boost population immunity, adding that the company is already working on a new jab for the Omicron variant. [articlepreview id="700470" link="

Among the seven Coronavirus vaccines which showed effective immune response are AstraZeneca, Pfizer, Novavax, Janssen, Moderna, Valneva and Curevac.

DEAR DR. ROACH: Im 71 and have had both Moderna COVID-19 vaccination shots. When I called my doctor to inquire about a Moderna booster, I was told one was not available now but that I could take the Pfizer booster. Can you confirm this? Im a little wary of taking another type of booster shot. [] The post Is it safe to switch vaccines for your covid booster? appeared first on Lewiston Sun Journal .